跳至主要内容
临床试验/NCT04727658
NCT04727658终止2 期

Linac FRACtionated Radiosurgical THALamotomy in Tremors : a Phase II Study

Centre Hospitalier Universitaire de Nice2 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2021年7月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
终止
入组人数
9
试验地点
2
主要终点
Treatment toxicity

研究概览

简要总结

Radiosurgical thalamotomy on GammaKnife has been shown to be effective in the management of tremors. However, several teams describe a significant risk of severe neurological complications. In addition, fitting the invasive frame and the need to travel to GammKnife centers often limit access to treatment in this population of elderly patients.

Linear accelerators have greatly improved their precision, now reaching that of GammaKnife. A possible alternative is therefore to treat patients on linear accelerators, without an invasive frame.

The objective of the FRACTHAL study is to assess the feasibility and safety of treatment of essential and / or parkinsonian tremor by fractional radiosurgical thalamotomy on a linear accelerator.

The main hypothesis of the FRACTHAL study is based on the fact that dividing the dose into 3 sessions will both protect healthy tissue around the target while maintaining therapeutic efficacy on the treatment target.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient with disabling essential tremor, dystonic and / or parkinsonian in one or more limbs superiors ;
  • patient contraindicated or refusing deep brain stimulation ;
  • patient ≥ 18 years old,
  • women of childbearing potential must take effective contraception ;
  • signature of informed consent ; p- atients who benefited from contralateral thalami c stimulation can be included in the study

排除标准

  • brain irradiation history ;
  • contraindication or inability to perform injected MRI ;
  • life expectancy <12 months ;
  • claustrophobic patient who cannot stand the radiotherapy mask ;
  • abnormal anatomy of the thalamic region ;
  • treatment with a trial drug within 30 days of entering the study ;
  • presence of medical, psychological, social or geographic factors likely to modify the patient's compliance with the protocol under study or the monitoring or signing of the consent

研究组 & 干预措施

Radiosurgical thalamotomy on GammaKnife

Experimental

干预措施: Radiosurgical thalamotomy on GammaKnife (Radiation)

结局指标

主要结局

Treatment toxicity

时间窗: 12 months

The treatment will be considered toxic in the event of the appearance, within 12 months after treatment, of non-regressive toxicity of grade\> 1 according to the NCI-CTCAE V5.0 scale (symptomatic neurological deficit interfering with daily activities), and that this deficit is related to the treatment.

次要结局

  • Treatment accuracy(At 6 and 12 months)
  • Tremor improvement(At 3, 6 and 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验